With this year’s ‘quad-demic’ of flu, Covid, RSV and norovirus starting to surge, here are the symptoms to watch for and how ...
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
TipRanks on MSN
Cocrystal Pharma reports Q3 EPS (19c) vs (49c) last year
We expect to begin enrolling participants in the first quarter of 2026 for our norovirus challenge study evaluating CDI-988, our oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results